Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Bianca Flexa-RibeiroPrograma de Pós-Graduação em Ciências Farmacêuticas, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.
Manoel D N GarciaDepartment of Biological and Health Sciences, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.
Ana Carolina de J SilvaPrograma de Pós-Graduação em Ciências Farmacêuticas, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.
José Carlos T CarvalhoPrograma de Pós-Graduação em Ciências Farmacêuticas, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.ORCID 0000-0003-3662-9794
Leandro RochaDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Fluminense Federal University, Niterói 24210-346, RJ, Brazil.ORCID 0000-0003-0484-1918
Silvia Maria M FaustinoDepartment of Biological and Health Sciences, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.
Caio P FernandesPrograma de Pós-Graduação em Ciências Farmacêuticas, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.ORCID 0000-0002-6538-7360
Hellen F da SilvaDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Fluminense Federal University, Niterói 24210-346, RJ, Brazil.
Francisco P MachadoDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Fluminense Federal University, Niterói 24210-346, RJ, Brazil.ORCID 0000-0002-5332-9972
Lorane Izabel da S Hage-MelimPrograma de Pós-Graduação em Ciências Farmacêuticas, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.
Raimundo Nonato P SoutoPrograma de Pós-Graduação em Ciências Farmacêuticas, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.ORCID 0000-0002-8795-1217
Gisele da S BotasPrograma de Pós-Graduação em Ciências Farmacêuticas, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.ORCID 0000-0002-7023-0544
Rodrigo A S CruzPrograma de Pós-Graduação em Ciências Farmacêuticas, Campus Marco Zero, Federal University of Amapá, Macapá 68903-419, AP, Brazil.ORCID 0000-0003-1728-4145
Funding
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Programa Demanda SocialPROCAD-Amazônia Edital 21/2018Programa de Desenvolvimento da Pós-Graduação (PDPG) 0789/2020
6 · The paper itself
Abstract
Nano-emulsions of essential oils (EO) and their chemical constituents are promising raw materials for the ecological control of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.